SPATIAL ANALYSIS OF BRAIN AND OTHER CNS CANCERS INCIDENCE IN IRAQ DURING 2000-2015
Brain and other CNS cancers have evidenced increase in Iraq over the study period (2000-2015). Spatial variation of brain and CNS cancers in Iraq at the district level has not been explored. This study aimed to explore the spatial patterns of the Age-Standardized Incidence Rates (ASIRs) of brain and CNS cancers throughout Iraq (except Kurdish region) during 2000-2015 using spatial autocorrelation analyses. Data were obtained from the Iraqi Cancer Registry. The ASIRs were calculated according to geographical region (provinces and districts) for each period (2000-2004, 2005- 2009, and 2010-2015). spatial statistical tools were employed to evaluate hotspots, cold spots, spatial clustering and outliers for each period. Results showed a spatial correlation with hotspots, cold spots, and detecting spatial outliers. This study identified 7 districts as high-risk areas for brain and CNS cancers during 2010-2015, including Al-Sadir, Al-Kadhimiyah, Adhamia, Al-Karkh, Al-Rissafa, and Al-Madain districts in Baghdad province) and southern region (Abu-Al-Khaseeb district in Al-Basrah provinces, and we have evidenced an increase of brain and CNS cancers incidence rates during 2010-2015. The government efforts should focus on those regions, and the factors related to the spatial pattern of the brain and CNS cancers incidence in Iraq should be investigated.
Leece R, Xu J, Ostrom QT, Chen Y, et al., Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007. Neuro-oncology 2017; 19(11):1553-64.
Gittleman HR, Ostrom QT, Rouse CD, et al., Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer 2015; 121(1): 102-12.
Patel AP, Fisher JL, Nichols E, et al., Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 2019; 18(4):376-93.
McNeill K.A., Epidemiology of brain tumors. Neurologic clinics 2016; 34(4):981-98.
Annual Statistical Report 2015. Planning Directorate, Ministry of Health/ Environment, Republic of Iraq 2016: 4-5.
Waller LA. & Gotway CA., Applied spatial statistics for public health data. John Wiley & Sons, 2004: 227-234.
Legendre P. & M.J. Fortin, Spatial pattern and ecological analysis. Vegetatio 1989; 80(2):107-38.
Khodamoradi F, Ghoncheh M, Pakzad R, et al., The incidence and mortality of brain and central nervous system cancer and their relationship with human development index in the world. World Cancer Res J 2017; 4:e985.
Araghi M, Roshandel G, Hasanpour-Heidari S, et al., Incidence of Malignant Brain and Central Nervous System Tumors in Golestan, Iran, 2004–2013. Archives of Iranian Medicine (AIM) 2020; 23(1)
Jung KW, Won YJ, Kong HJ, et al., Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer research and treatment: official journal of Korean Cancer Association 2019; 51(2):417.
Al-Madouj A, Eldali A, Al-Zahrani AS, et al., Ten-year cancer incidence among nationals of the GCC states 1998–2007. Gulf Center for Cancer Control and Prevention. 2011.
Council S health, Cancer Incidence Report. Saudi Arabia, Saudi Cancer Registry 2014: 53-54.
Almutrafi A, Bashawry Y, AlShakweer W, et al., The Epidemiology of Primary Central Nervous System Tumors at the National Neurologic Institute in Saudi Arabia: A Ten-Year Single-Institution Study. Journal of Cancer Epidemiology 2020;2020.
Piñeros M, Sierra MS, Izarzugaza MI, et al., Descriptive epidemiology of brain and central nervous system cancers in Central and South America. Cancer epidemiology 2016; 44:S141-9.
Salhab HA, Khachfe HH, Fares MY, et al., Central nervous system cancers in the Middle East and North Africa (MENA) region: where does Lebanon stand. Chinese clinical oncology. 2020 Apr 23.
Bray F, Ferlay J, Soerjomataram I, et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018; 68(6):394-424.
FARMANFARMA KK, Mohammadian M, Shahabinia Z, et al., BRAIN CANCER IN THE WORLD: AN EPIDEMIOLOGICAL REVIEW. World Cancer Research Journal 2019; 6:5.
Darefsky A.S. & R. Dubrow, International variation in the incidence of adult primary malignant neoplasms of the brain and central nervous system. Cancer Causes & Control 2009; 20(9):1593-604.